U.S. markets closed

Sinopharm Group Co. Ltd. (SHTDF)

OTC Markets OTCPK - OTC Markets OTCPK Precio retrasado. Moneda en USD.
Añadir a la lista de seguimiento
2.8000-0.1400 (-4.76%)
Al cierre: 11:19AM EDT

Sinopharm Group Co. Ltd.

Sinopharm Group Building
No. 385, East Longhua Road Huangpu District
Shanghai 200023
China
86 21 2305 2666
https://www.sinopharmgroup.com.cn

Sector(es)Healthcare
IndustriaMedical Distribution
Empleados a tiempo completo115,959

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Qingming YuExecutive Chairman of the Board927.73kN/D1964
Mr. Yong LiuPresident & Executive Director895.91kN/D1969
Ms. Xiaojuan LiChief Financial OfficerN/DN/D1976
Mr. Yijian WuSecretary to the Board, Company Secretary & Authorised RepresentativeN/DN/D1970
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Gestión corporativa

La calificación ISS Governance QuickScore de Sinopharm Group Co. Ltd. a partir del 1 de junio de 2024 es 8. Las puntuaciones principales son Auditoría: 6; Junta: 9; Derechos del accionista: 10; Compensación: 2.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.